- Home
- NVS vs WFC Comparison
NVS vs WFC Comparison
Compare NVS & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$166.00
Company Overview
Basic Information| Metric | NVS | WFC |
|---|---|---|
| Founded | 1895 | 1852 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.3B | 290.6B |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVS | WFC |
|---|---|---|
| Price | $166.00 | $87.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 16 |
| Target Price | ★ $118.00 | $97.37 |
| AVG Volume (30 Days) | 2.4M | ★ 16.9M |
| Earning Date | 02-04-2026 | 01-14-2026 |
| Dividend Yield | 1.90% | ★ 2.07% |
| EPS Growth | ★ 21.81 | 16.57 |
| EPS | ★ 7.15 | 6.26 |
| Revenue | $56,674,000,000.00 | ★ $80,041,000,000.00 |
| Revenue This Year | $2.51 | $11.53 |
| Revenue Next Year | $4.14 | $4.57 |
| P/E Ratio | $22.81 | ★ $13.89 |
| Revenue Growth | ★ 9.57 | 2.67 |
| 52 Week Low | $97.72 | $58.42 |
| 52 Week High | $163.42 | $97.76 |
Technical Indicators
Market Signals| Indicator | NVS | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 77.57 | 41.67 |
| Support Level | $149.38 | $85.09 |
| Resistance Level | $158.80 | $95.09 |
| Average True Range (ATR) | 2.19 | 2.91 |
| MACD | 0.97 | -0.46 |
| Stochastic Oscillator | 95.97 | 24.35 |
Price Performance
Historical Comparison NVS
WFC
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.